What is PEGylation?

PEGylation is the attachment of one or more polyethylene glycol (PEG) chains to a peptide or protein. It is one of the two main strategies for making a short-lived molecule last longer in circulation.

What it changes

• Hydrodynamic size. PEG chains are heavily hydrated, so a PEGylated peptide behaves as though it were far larger than its molecular weight suggests. Once it exceeds the kidney's filtration threshold, renal clearance slows sharply.
• Proteolytic protection. The PEG shell sterically shields the peptide backbone from enzymes that would otherwise cleave it.
• Immunogenicity. Masking the surface can reduce immune recognition.

The trade-off

The same shell that protects the peptide also gets in the way of its receptor. PEGylation commonly reduces binding potency, so the design question is whether the gain in exposure time outweighs the loss in per-molecule activity. Chain length and attachment site are tuned for exactly this balance.

The approach is well established in approved medicines — pegfilgrastim and peginterferon are PEGylated proteins — rather than being research-only chemistry.

The alternative strategy is albumin binding, which achieves a similar extension by a different route: hitching to a long-lived carrier protein instead of building a shell. Research use only. Not medical advice.